INTERCEPT PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, October 15, 2014, a trademark application was filed for INTERCEPT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the INTERCEPT PHARMACEUTICALS trademark a serial number of 86424429. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 4, 2025. This trademark is owned by Intercept Pharmaceuticals, Inc.. The INTERCEPT PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations used to treat chronic liver diseases
intercept pharmaceuticals

General Information

Serial Number86424429
Word MarkINTERCEPT PHARMACEUTICALS
Filing DateWednesday, October 15, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 4, 2025
Registration Number5570855
Registration DateTuesday, September 25, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements

Description of MarkThe mark consists of the words "INTERCEPT" and "PHARMACEUTICALS" in stylized lettering, on either side of two overlapping quadrilateral figures, with the overlap in contrasting white which represents background and not a part of the mark.
Goods and Servicespharmaceutical preparations used to treat chronic liver diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 4, 2025
Primary Code005
First Use Anywhere DateMonday, April 30, 2007
First Use In Commerce DateSunday, December 31, 2017

Trademark Owner History

Party NameIntercept Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001
Party NameIntercept Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001
Party NameIntercept Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10011

Trademark Events

Event DateEvent Description
Thursday, January 29, 2015ASSIGNED TO EXAMINER
Saturday, October 18, 2014NEW APPLICATION ENTERED
Wednesday, October 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 23, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, April 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 4, 2015NON-FINAL ACTION WRITTEN
Wednesday, February 4, 2015NON-FINAL ACTION E-MAILED
Wednesday, February 4, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 7, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 22, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 22, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 29, 2015ASSIGNED TO LIE
Thursday, July 28, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, May 13, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 2, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 15, 2016SOU TEAS EXTENSION RECEIVED
Friday, January 15, 2016SOU EXTENSION 1 FILED
Tuesday, February 23, 2016SOU EXTENSION 1 GRANTED
Saturday, February 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2017SOU EXTENSION 4 GRANTED
Thursday, July 28, 2016SOU EXTENSION 2 FILED
Friday, August 5, 2016SOU EXTENSION 2 GRANTED
Saturday, August 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2017SOU TEAS EXTENSION RECEIVED
Monday, January 30, 2017SOU EXTENSION 3 FILED
Monday, January 30, 2017SOU EXTENSION 3 GRANTED
Wednesday, February 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2017SOU TEAS EXTENSION RECEIVED
Monday, July 24, 2017SOU EXTENSION 4 FILED
Monday, August 20, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 26, 2018SOU TEAS EXTENSION RECEIVED
Friday, January 26, 2018SOU EXTENSION 5 FILED
Monday, January 29, 2018SOU EXTENSION 5 GRANTED
Tuesday, January 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 27, 2018TEAS STATEMENT OF USE RECEIVED
Friday, July 27, 2018USE AMENDMENT FILED
Monday, July 30, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 21, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 25, 2018REGISTERED-PRINCIPAL REGISTER
Monday, September 25, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 4, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

pharmaceuticals intercept liver diseases chronic treat preparations used pharmaceutical